Kiribati vs Mayotte: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Kiribati
0.9%
in 2024
Mayotte
0.8%
in 2024
Kiribati rank
35th
Mayotte rank
37th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Kiribati
- Mayotte
How they compare
Kiribati currently reports 0.9% against 0.8% in Mayotte, a difference of 0.1%.
That makes Kiribati's figure about 1.1 times Mayotte's.
Across all 10 years both countries report, Kiribati has been ahead every year.
Kiribati ranks 35th and Mayotte ranks 37th of 215 countries.
Kiribati has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Kiribati | Mayotte | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.9% | 1.2% | 0.7% | Kiribati |
| 2020s | 1.1% | 0.8% | 0.3% | Kiribati |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Kiribati or Mayotte?
- Kiribati, at 0.9% against 0.8% in Mayotte as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Kiribati and Mayotte?
- 0.1%, with Kiribati ahead.
- How many years of comparable data are there for Kiribati and Mayotte?
- 10 years are reported by both, from 2015 to 2024.
- How do Kiribati and Mayotte rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Kiribati ranks 35th and Mayotte ranks 37th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.